Efficacy of levetiracetam in a patient with chronic motor tic, rolandic epilepsy and attention and behavioral disorder;Eficacia del levetiracetam en un paciente con tics motores crónicos, epilepsia rolándica y trastorno de la atención y del comportamiento

Revista de Neurologia

Volumn 49, Issue 9, 2009, Pages 502-503

  Fernández Mayoralas, Daniel Martín ^a   Fernandez Jaen A ^a   Munoz Jareno N ^b   Calleja Perez B ^c   Arroyo Gonzalez R ^a  

^a Neurology Service   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c Centro de Salud Linneo   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; VALPROIC ACID;

ATTENTION DEFICIT DISORDER; BEHAVIOR; CASE REPORT; CHILD; CHRONIC MOTOR TIC; COGNITIVE DEFECT; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; HALLUCINATION; HUMAN; LETTER; MALE; MENTAL DISEASE; MONOTHERAPY; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; RELAPSE; REM SLEEP; ROLANDIC EPILEPSY; SCHOOL CHILD; SYMPTOM; TIC; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 73949135024     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4909.2009216     Document Type: Letter

References (26)

1. Deonna TD, Roulet-Pérez. Cognitive and behavioural disorders of epileptic origin in children. London: Mac Keith Press; 2005.
2. Al-Twaijri WA, Shevell MI. Atypical benign epilepsy of childhood with rolandic spikes: features of a subset requiring more than one medication for seizure control. J Child Neurol 2002; 17: 900-3.
3. Holtmann M, Matei A, Hellmann U, Becker K, Poustka F, Schmidt MH. Rolandic spikes increase impulsivity in ADHD -a neuropsychological pilot study. Brain Dev 2006; 28: 633-40.
4. Datta A, Sinclair DB. Benign epilepsy of childhood with rolandic spikes: typical and atypical variants. Pediatr Neurol 2007; 36: 141-5.
5. Palencia R. Epilepsias parciales benignas de la infancia. Rev Neurol 2001; 33: 1167-79.
6. Tavares S, Almeida RM, Figueiroa SM, Temudo T. Epilepsia rolándica. Análisis de las características clínicas, electrofisiológicas, tratamiento y pronóstico en 87 pacientes. Rev Neurol 2005; 41: 327-30.
7. Stephani U, Carlsson G. The spectrum from BCECTS to LKS: the rolandic EEG trait -impact on cognition. Epilepsia 2006; 47: 67-70.
8. Kavros PM, Clarke T, Strug LJ, Halperin JM, Dorta NJ, Pal DK. Attention impairment in rolandic epilepsy: systematic review. Epilepsia 2008; 49: 1570-80.
9. Binnie CD. Cognitive impairment during epileptiform discharges: is it ever justifiable to treat the EEG? Lancet Neurol 2003; 2: 725-30.
10. Massa R, De Saint-Martin A, Carcangiu R, Rudolf G, Seegmuller C, Kleitz C, et al. EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 2001; 57: 1071-9.
11. Bello-Espinosa LE, Roberts SL. Levetiracetam for benign epilepsy of childhood with centrotemporal spikes -three cases. Seizure 2003; 12: 157-9.
12. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007; 9: 353-412.
13. Tapiador-Sanjuán MJ, Zuazo-Zamalloa E, Garaizar-Axpe C, Prats-Viñas JM. Tics y carbamazepina en la epilepsia parcial benigna de la infancia. Neurología 1995; 1: 59-60.
14. Holtmann M, Korn-Merker E, Boenigk HE. Carbamazepine-induced combined phonic and motor tic in a boy with Down's syndrome. Epileptic Disord 2000; 2: 39-40.
15. Engler F, Maeder-Ingvar M, Roulet E, Deonna T. Treatment with sulthiame (Ospolot) in benign partial epilepsy of childhood and related syndromes: an open clinical and EEG study. Neuropediatrics 2003; 34: 105-9.
16. Carreño M. Levetiracetam. Drugs Today (Barc) 2007; 43: 769-94.
17. Verrotti A, Coppola G, Manco R, Ciambra G, Iannetti P, Grosso S, et al. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures. Seizure 2007; 16: 271-5.
18. Coppola G, Franzoni E, Verrotti A, Garone C, Sarajlija J, Operto F, et al. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev 2007; 29: 281-4.
19. Kossoff EH, Los JG, Boatman DF. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy Behav 2007; 11: 514-7.
20. Kossoff EH, Boatman D, Freeman JM. Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav 2003; 4: 571-5.
21. Fernández-Jaén A, Fernández-Mayoralas DM, Muñoz-Jareño N, Calleja-Pérez B. An openlabel, prospective study of levetiracetam in children and adolescents with Tourette syndrome. Eur J Paediatr Neurol. doi:10.1016/j.ejpn.2008.12.006
22. Awaad Y, Michon AM, Minarik S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005; 20: 714-8.
23. Smith-Hicks CL, Bridges D, Paynter N, Singer HS. A double-blind randomized placebocontrol trial of levetiracetam in Tourette syndrome. Mov Disord 2007; 22: 1764-70.
24. Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 2001; 56: 599-604.
25. Andrade R, García-Espinosa A, De la Cruz-Turruelles A, Machado-Rojas A, Arteche-Prior M, Díaz-Pedraza A. Heminegligencia, déficit cognitivo transitorio y actividad intercrítica en la epilepsia rolándica. Rev Neurol 2007; 44: 537-40.
26. Callén-Soto A, Pérez-Pérez S, Robles-Del Olmo B. Estatus epiléptico no convulsivo revertido con levetiracetam endovenoso. Rev Neurol 2008; 47: 501-2.